What are you looking for?


Diverse range of ICU/IPD Products
We have an injectable portfolio with a strength of 100 Plus products which caters to almost the entire spectrum of Hospitalized patient’s need while assuring quality, affordability & safety.
Proactive quality assurance
Our goal is to manufacture and market zero defect products. We have meticulously planned and built a series of quality control measures which have earned us the TUV NORD ISO & Star Export House certifications.
Zyphars Critical Care Division focus on critical care ICU/IPD products. Today Critical Care Division is dedicated to all major specialty with field strength of 150 dedicated sales force covering 18000+ Doctors of leading Hospitals/ICUs set ups across India.
With the constant thought of excellence being a continual process, Zyphars Critical Care Division market a wide range of quality and affordable injectables trusted by medical professionals across India.
We emphasize on services aimed at improving patient outcomes and customer needs. With more than a decade of dedication, we made a successful domestic presence through quality products complying with international standards such as cGMPs, ISO 9001:2015 Quality management system, including an array of WHO Certified manufacturers and always continue to do so.

Innovative Product Portfolio Of 40+ Products In The Critical Care Segment

1st to launch one of its kind RDA compliant multivitamin & multimineral Tablet – Brio-1
First to launch unique non-refrigerated, live & lyophilized probiotic - Procraft 24
First in the country to introduce most economical Meropenem - Zypenem
Second in the country to launch Tigecycline - Tigaphar
Third in the country to launch Caspofungin - Canducid
Novel fourth generation cephalosporin - Zyfrom